✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Windlas Biotech Ltd.

WINDLAS

Market Cap
₹2,147 Cr.
P/E
34.79

Windlas Biotech Ltd.

  • Windlas Biotech
  • Vimta Labs
  • Indoco Remedies
  • TJI Pharma - Small Cap
FAQs on Windlas Biotech Ltd. Shareprice

Windlas Biotech has given better returns compared to its competitors.
Windlas Biotech has grown at ~57.21% over the last 3yrs while peers have grown at a median rate of 6.0%

Yes, Windlas Biotech is expensive.
Latest PE of Windlas Biotech is 34.79, while 3 year average PE is 24.11.
Also latest EV/EBITDA of Windlas Biotech is 23.53 while 3yr average is 13.02.

View FAQ's On Business
Growth Table
  • Windlas Biotech Ltd.
  • Vimta Labs
  • Indoco Remedies
Balance Sheet
  • Windlas Biotech Ltd.
  • Vimta Labs
  • Indoco Remedies
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Windlas Biotech Ltd.
  • Vimta Labs
  • Indoco Remedies
Cash Flow
  • Windlas Biotech Ltd.
  • Vimta Labs
  • Indoco Remedies
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Windlas Biotech Ltd.
  • Vimta Labs
  • Indoco Remedies
Quarterly Results
  • Windlas Biotech Ltd.
  • Vimta Labs
  • Indoco Remedies
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Windlas Biotech Ltd. Financials

Balance sheet of Windlas Biotech is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Windlas Biotech is increasing.
Latest debt of Windlas Biotech is -₹16.29 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹61.76 Crs.

Yes, profit is increasing.
The profit of Windlas Biotech is ₹61.71 Crs for TTM, ₹58.19 Crs for Mar 2024 and ₹42.63 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Windlas Biotech latest dividend payout ratio is 19.66% and 3yr average dividend payout ratio is 19.77%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech